Company Filing History:
2 out of 18 
2 out of 6 Years Active: 2015-2018
Title: The Innovative Contributions of Emanuela Marcenaro
Introduction
Emanuela Marcenaro, an accomplished inventor from Genova-Pegli, Italy, has made significant strides in the field of immunology. With two patents to her name, her work focuses on developing new therapeutic strategies to treat immune disorders, particularly autoimmune and inflammatory diseases.
Latest Patents
Emanuela Marcenaro's latest patents involve monoclonal antibodies directed against NKG2A. These inventions relate to methods for treating immune disorders by utilizing antibodies and other compounds that inhibit the stimulation of NKG2A receptors on natural killer (NK) cells. This innovative approach contributes to the lysis of dendritic cells implicated in the pathology of such disorders, opening new pathways for therapeutic interventions.
Career Highlights
Throughout her career, Emanuela has worked with prominent organizations, including Innate Pharma and the University of Genova. Her research has not only advanced scientific understanding but has also paved the way for practical applications in treating complex immune-related conditions.
Collaborations
In her journey, Emanuela has collaborated with esteemed colleagues such as Alessandro Moretta and Francois Romagne. These partnerships have fostered an environment of innovation and have played a crucial role in the development of her groundbreaking inventions.
Conclusion
Emanuela Marcenaro exemplifies the role of inventors in pushing the boundaries of science and medicine. Her contributions, marked by her patents and collaborations, continue to inspire future advancements in immunology and the development of therapies for autoimmune and inflammatory disorders.